Blow Fill Seal (BFS) technology is becoming more popular as a packaging solution in the pharmaceutical industry. Using a single integrated machine, produce aseptically prepared medications without the need for human intervention. The BFS technology industry is estimated to reach US$2.6 billion by the end of 2021, according to Future Market Insights (FMI). The market’s overall growth prognosis remains optimistic, particularly as demand for effective packaging technology grows across industries.
The plastic is blown out without contamination from the outside, loaded with formulated items, and continually sealed inside the machine using BFS technology. It is a low-energy, rapid, accurate, and safe method of medication filling. The materials are frequently recyclable and last longer than glass. The machine may manufacture a variety of shapes based on the needs of the end-users. Many end customers choose BFS technology because it boosts throughput and allows for contamination-free packaging.
Over the past 20 years, medical adherence has created a very important situation for the healthcare and pharmaceutical industries-
For example, in the United States, an FMI study found that ~40%-50% of prescribed medications were not taken adequately by patients. Alongside this, a study conducted by Intercontinental Medical Statistics (IMS) Health notes that not taking medicines at the right time and right can cost patients more than $200 billion.
Blow Fill Seal (BFS) Technology Market Segmentation–BFS Technology Market By Product Type (Bottles, Ampules, Vials), Material (PE, PP, and Others), End-use (Pharmaceuticals, Food & Beverage, Cosmetics & Personal Care, and Others) & Region – Forecast 2022 – 2031
